Rule S, Barreto WG, Briones J, Carella AM, et al. Efficacy and safety assessment of prolonged maintenance with subcutaneous rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: results of the Phase III MabCute study. Haematologica 2021 Jun 17. doi: 10.3324/haematol.2020.274803.
PMID: 34134469